Literature DB >> 15694378

5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes.

Keiichi Ikeda1, Katsuyoshi Tojo, Chikara Otsubo, Takashi Udagawa, Kensuke Kumazawa, Masahiro Ishikawa, Goro Tokudome, Tatsuo Hosoya, Naoko Tajima, William C Claycomb, Kazuwa Nakao, Masahiro Kawamura.   

Abstract

Some reports showed that serotonergic system might have existed and that 5-hydroxytryptamine (5-HT) was detected in the hamster heart. The source of 5-HT in the heart, however, remains to be fully elucidated. So the present study was designed to define serotonergic system and to clarify which cell could produce 5-HT in the heart. As a result, 5-HT was detected in homogenates of HL-1 cardiomyocytes by high performance liquid chromatography with fluorescence detection, but not in those of neonatal rat non-cardiomyocytes (NMCs). And TPH and AADC mRNAs were expressed in HL-1 cardiomyocytes and neonatal rat cardiomyocytes (MCs), not in NMCs. mRNAs of 5-HT(2A) receptor were detected in both MCs and NMCs, and those of 5-HT(2B) receptor in NMCs. These findings definitively demonstrate that 5-HT is secreted from the myocytes of the heart and strongly implied that 5-HT might play a certain role in cardiac physiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694378     DOI: 10.1016/j.bbrc.2005.01.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  On the presence of serotonin in mammalian cardiomyocytes.

Authors:  Klaus Pönicke; Ulrich Gergs; Igor B Buchwalow; Steffen Hauptmann; Joachim Neumann
Journal:  Mol Cell Biochem       Date:  2012-02-25       Impact factor: 3.396

Review 3.  Monoamine oxidases as sources of oxidants in the heart.

Authors:  Nina Kaludercic; Jeanne Mialet-Perez; Nazareno Paolocci; Angelo Parini; Fabio Di Lisa
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

4.  The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2-GATA4 Signaling Pathway.

Authors:  Kana Shimizu; Yoichi Sunagawa; Masafumi Funamoto; Hiroki Honda; Yasufumi Katanasaka; Noriyuki Murai; Yuto Kawase; Yuta Hirako; Takahiro Katagiri; Harumi Yabe; Satoshi Shimizu; Nurmila Sari; Hiromichi Wada; Koji Hasegawa; Tatsuya Morimoto
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.